Pneumagen doses first subject in Phase II influenza antiviral trial
The company expects preliminary topline results from the trial in the first half of 2023.
Europe
Latest in
Europe
Digital media: Europe sees hiring jump in clinical trial operation roles
The number of roles in Europe made up 17.5% of total digital media jobs.
By
BeiGene reports Phase III tislelizumab data in hepatocellular cancer
Tislelizumab’s safety profile was in line with prior trials without any new safety signals observed.
The NHS acts to tackle the gender health gap in the UK
A strategy proposed by the DHSC sets bold ambitions to tackle deep-rooted, systemic issues within the UK’s healthcare system.
By
Cocrystal selects hVIVO as CRO for Phase IIa Influenza antiviral trial
The trial of CC-42344 in participants who are challenged with influenza A is planned to begin in the second half…
Hutchmed’s Phase III colorectal cancer trial meets primary endpoint
Fruquintinib’s safety profile in this trial was in line with priorly reported data from trials.
Union begins enrolment in Phase IIb atopic dermatitis trial
The company plans to carry out the trial in centres in Europe and the US.
Roche’s subcutaneous Tecentriq meets Phase III NSCLC co-primary endpoints
In the trial, Tecentriq’s subcutaneous formulation safety profile was in line with that of IV Tecentriq.